Scientists at The University of Toledo investigating improvements to a commonly used chemotherapy drug have discovered an entirely new class of cancer-killing agents that show promise in eradicating cancer stem cells.
Their findings could prove to be a breakthrough in not only treating tumors, but ensuring cancer doesn’t return years later — giving peace of mind to patients that their illness is truly gone.
“Not all cancer cells are the same, even in the same tumor,” said Dr. William Taylor, a professor in the Department of Biological Sciences in the UToledo College of Natural Sciences and Mathematics. “There is a lot of variability and some of the cells, like cancer stem cells, are much nastier. Everyone is trying to figure out how to kill them, and this may be one way to do it.”
Taylor and Dr. L.M. Viranga Tillekeratne, a professor in the Department of Medicinal and Biological Chemistry in the UToledo College of Pharmacy and Pharmaceutical Sciences, reported their findings in a paper recently published in the journal Scientific Reports.
Cancer stem cells are an intriguing target for researchers because of their potential to re-seed tumors.
When doctors remove a tumor surgically or target it with chemotherapy drugs or radiation therapy, the cancer may appear to be gone. However, evidence suggests that a tiny subpopulation of adaptable cancer cells can remain and circulate through the body to seed new metastasis in far-off locations.
Those cancer stem cells, Taylor said, are similar to dandelions in a well-manicured lawn.
“You could chop the plant off, but it will drop a seed. You know the seeds are there, but they’re hiding,” he said. “You pull one weed out and another comes up right after it. Cancers can be like this as well.”
The small molecule they have isolated appears to lock on to those stem cells and kill them by blocking their absorption of an amino acid called cystine.
UToledo was awarded a patent for the discovery late last year.
For Tillekeratne and Taylor, uncovering a new class of therapeutic molecules could prove to be an even larger contribution to cancer research than the project they initially envisioned.
“At present, there are no drugs that can kill cancer stem cells, but people are looking for them,” Tillekeratne said. “A lot of drugs are discovered by serendipity. Sometimes in research if you get unexpected results, you welcome that because it opens up a new line of research. This also shows the beauty of collaboration. I wouldn’t have been able to do this on my own, and [Taylor] wouldn’t have been able to do it on his own.”
Tillekeratne has received a three-year, $449,000 grant from the National Institutes of Health National Cancer Institute to continue testing the effectiveness of the newly identified therapy.
Because the molecules so selectively target cancer stem cells, it’s possible they could ultimately be paired with other chemotherapy drugs to deliver a more comprehensive treatment.
However, the researchers have found their agents show stand-alone promise in treating sarcomas and a subtype of breast cancer known as claudin-low breast cancer, which represents up to 14 percent of all breast cancers and can be particularly difficult to treat.
The Latest on: Cancer-killing agents
via Google News
The Latest on: Cancer-killing agents
- A pill to tackle bowel canceron September 30, 2020 at 5:00 pm
It targets an enzyme that makes the tumour produce a cancer-killing agent, unlike infused therapy which visits other body sites in addition to the tumour. Recent trials involving 1,200 patients ...
- Gynecologic Oncologists Continue to Pursue Novel Agents, Immunotherapy in Ovarian Canceron September 30, 2020 at 1:47 pm
Caroline Billingsley, MD, spoke to established and emerging treatment modalities in ovarian cancer and the successes and pitfalls of key clinical trials of antibody-drug conjugates and immunotherapy ...
- Boosting immuno-oncology drugs by recruiting immune messenger cellson September 21, 2020 at 5:29 am
A popular idea for improving PD-1/L1 checkpoint inhibitors focuses on turning “cold” tumors that often evade the immune system into “hot” ones by recruiting more cancer-killing immune ...
- ‘FedEx’ stem cells may deliver drugs to kids’ brain canceron September 9, 2020 at 4:59 pm
Previously, researchers showed in preclinical studies they could flip skin cells into stem cells that hunt and deliver cancer-killing drugs ... potent cytotoxic agents directly into the tumor.” ...
- Markers may predict patient response to immune therapy of canceron September 7, 2020 at 12:04 pm
Using this model system, the researchers found that the responding tumors contained higher numbers of cancer-killing "cytotoxic ... unlikely to respond to these agents." About the Massachusetts ...
- New drug joins breast cancer battleon September 6, 2020 at 4:59 pm
It delivers oral chemotherapy, where pills replace injections. Each tablet contains a cancer-killing chemotherapy agent called 5FU. The agent is only activated when it reaches the site of the ...
- Novel markers may predict patient response to immune checkpoint inhibitorson September 6, 2020 at 4:59 pm
the researchers found that the responding tumors contained higher numbers of cancer-killing "cytotoxic" T immune cells and fewer numbers of certain immune suppressor cells early after the start of ...
- Tiny bubbles could deliver cancer-killing drugson September 13, 2019 at 11:37 am
“What we’ve done is improve a therapeutic approach to delivering enzyme-producing genes that can convert certain drugs into toxic agents and target tumors,” says lead author Masamitsu ...
- Cutting-Edge Breast Cancer Therapyon March 13, 2014 at 1:21 pm
These treatments send toxic cancer-killing agents directly to tumor cells, avoiding the "fallout" damage to healthy cells that happens with broad-range chemotherapies and radiation. The more that ...
- VG Life Sciences Incon May 4, 2013 at 7:22 am
The Company's MDT compounds impede tumor cells' ability to meet their energy requirements, leaving cancer cells vulnerable to cancer-killing agents. Its autoimmune therapy, TPT, eliminates a ...
via Bing News